
### [MONDO:0019787](http://purl.obolibrary.org/obo/MONDO_0019787)
**Label:** severe immune-mediated enteropathy

**Subclasses:** [MONDO:0010580](http://purl.obolibrary.org/obo/MONDO_0010580) (immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome), [MONDO:0015173](http://purl.obolibrary.org/obo/MONDO_0015173) (autoimmune enteropathy type 2), [MONDO:0015174](http://purl.obolibrary.org/obo/MONDO_0015174) (autoimmune enteropathy type 3), [MONDO:0013863](http://purl.obolibrary.org/obo/MONDO_0013863) (combined immunodeficiency due to LRBA deficiency), [MONDO:0013599](http://purl.obolibrary.org/obo/MONDO_0013599) (autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome), 

**Corr. equiv. classes:** [Orphanet:391487](http://www.orpha.net/ORDO/Orphanet_391487), [Orphanet:37042](http://www.orpha.net/ORDO/Orphanet_37042), [OMIM:614700](http://purl.obolibrary.org/obo/OMIM_614700), [Orphanet:103917](http://www.orpha.net/ORDO/Orphanet_103917), [OMIM:304790](http://purl.obolibrary.org/obo/OMIM_304790), [Orphanet:445018](http://www.orpha.net/ORDO/Orphanet_445018), [Orphanet:103916](http://www.orpha.net/ORDO/Orphanet_103916), [OMIM:614162](http://purl.obolibrary.org/obo/OMIM_614162), 

**Class expressions from DL-Learner:**

- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011473](http://purl.obolibrary.org/obo/HP_0011473) (Villous atrophy) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011472](http://purl.obolibrary.org/obo/HP_0011472) (Abnormality of small intestinal villus morphology) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) 68.75%
- [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) 68.75%
- [HP:0002244](http://purl.obolibrary.org/obo/HP_0002244) (Abnormality of the small intestine) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%
- [HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%
- [HP:0001890](http://purl.obolibrary.org/obo/HP_0001890) (Autoimmune hemolytic anemia) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002958](http://purl.obolibrary.org/obo/HP_0002958) (Immune dysregulation) 68.75%


